Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

Eugene McLaurin,Nicholas P. Marsico,Stacey L. Ackerman,Joseph B. Ciolino,Julia M. Williams,Linda Villanueva,David A. Hollander

Ocular Itch Relief with Alcaftadine 0.25% Versus Olopatadine 0.2% in Allergic Conjunctivitis: Pooled Analysis of Two Multicenter Randomized Clinical Trials

2014

Eugene McLaurin
Nicholas P. Marsico
Stacey L. Ackerman
Joseph B. Ciolino
Julia M. Williams
Linda Villanueva
David A. Hollander

Introduction The efficacy and safety of the once-daily topical ophthalmic solutions, alcaftadine 0.25% and olopatadine 0.2%, in preventing ocular itching associated with allergic conjunctivitis were evaluated.

Keywords:

Dermatology
Ophthalmology
Anesthesia
Itching
Alcaftadine
Randomized controlled trial
Olopatadine
Anti-Allergic Agents
Ophthalmic solutions
Olopatadine Hydrochloride
Allergic conjunctivitis
Medicine
Itch Relief
pooled analysis

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations